OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • May 3rd, 2021 • ImmunityBio, Inc. • Biological products, (no disgnostic substances) • New York
Reference is made to that certain Open Market Sale Agreement, dated as of April 30, 2021 (the “Agreement”) by and between ImmunityBio, Inc., a Delaware corporation (the “Company”), and Jefferies LLC. Capitalized terms used without definition herein shall have the meanings assigned thereto in the Agreement.
